tellurium has been researched along with potassium-periodate* in 2 studies
2 other study(ies) available for tellurium and potassium-periodate
| Article | Year |
|---|---|
Enhanced chemiluminescence of the fluorescein-KIO
In this paper, a novel chemiluminescence (CL) system was introduced based on the use of CdTe quantum dots (QDs) with the mixture solutions of fluorescein and potassium periodate (KIO Topics: Cadmium Compounds; Catechols; Fluorescein; Kinetics; Limit of Detection; Luminescence; Luminescent Agents; Luminescent Measurements; Periodic Acid; Potassium Compounds; Quantum Dots; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tellurium; Water | 2018 |
Size-dependent active effect of cadmium telluride quantum dots on luminol-potassium periodate chemiluminescence system for levodopa detection.
It was found that cadmium telluride (CdTe) quantum dots (QDs) with different sizes can have a great sensitizing effect on chemiluminescence (CL) emission from luminol-potassium periodate (KIO4) system. Levodopa, a widely prescribed drug in the treatment of Parkinson's disease, could inhibit luminol-KIO4-CdTe QDs CL reaction in alkaline solution. The inhibited CL intensity was proportional to the concentration of levodopa in the range from 8.0 nM to 10.0 μM. The detection limit was 3.8 nM. This method has been successfully applied to determine levodopa in pharmaceutical preparation and human urine and plasma samples with recoveries of 94.1-105.4%. This was the first work for inhibition effect determination of levodopa using a QD-based CL method. Topics: Cadmium Compounds; Equipment Design; Humans; Levodopa; Limit of Detection; Linear Models; Luminescent Measurements; Luminol; Particle Size; Periodic Acid; Potassium Compounds; Quantum Dots; Reproducibility of Results; Tellurium | 2015 |